Correction to: Scientific white paper on concentration-QTc modeling

Christine Garnett¹, Peter L Bonate², Qianyu Dang³, Georg Ferber⁴, Dalong Huang³, Jiang Liu⁵, Devan Mehrotra⁶, Steve Riley⁷, Philip Sager⁸, Christoffer Tornoe⁹, Yaning Wang⁵

Affiliations

¹ Division of Cardiovascular and Renal Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA. christine.garnett@fda.hhs.gov.
² Astellas Pharma Global Development, Northbrook, IL, USA.
³ Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
⁴ Statistik Georg Ferber GmbH, Riehen, Switzerland.
⁵ Division of Pharmacometrics, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
⁶ Biostatistics, Merck & Co., Inc., Gwynedd, PA, USA.
⁷ Clinical Pharmacology, Pfizer Inc., New York, NY, USA.
⁸ Stanford University, Stanford, CA, USA.
⁹ Clinical Reporting, Novo Nordisk A/S, Bagsværd, Denmark.

PMID: 29330761
DOI: 10.1007/s10928-017-9565-6

Published Erratum

Correction to: Scientific white paper on concentration-QTc modeling

Christine Garnett et al. J Pharmacokinet Pharmacodyn. 2018 Jun.

. 2018 Jun;45(3):399.

doi: 10.1007/s10928-017-9565-6.

Authors

Christine Garnett¹, Peter L Bonate², Qianyu Dang³, Georg Ferber⁴, Dalong Huang³, Jiang Liu⁵, Devan Mehrotra⁶, Steve Riley⁷, Philip Sager⁸, Christoffer Tornoe⁹, Yaning Wang⁵

Affiliations

¹ Division of Cardiovascular and Renal Products, Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA. christine.garnett@fda.hhs.gov.
² Astellas Pharma Global Development, Northbrook, IL, USA.
³ Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
⁴ Statistik Georg Ferber GmbH, Riehen, Switzerland.
⁵ Division of Pharmacometrics, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
⁶ Biostatistics, Merck & Co., Inc., Gwynedd, PA, USA.
⁷ Clinical Pharmacology, Pfizer Inc., New York, NY, USA.
⁸ Stanford University, Stanford, CA, USA.
⁹ Clinical Reporting, Novo Nordisk A/S, Bagsværd, Denmark.

PMID: 29330761
DOI: 10.1007/s10928-017-9565-6

Abstract

The original version of this article unfortunately contained an error in Equation 1 under the section "Pre-specified linear mixed effects model". The correct equation has given below.

PubMed Disclaimer

Erratum for

Scientific white paper on concentration-QTc modeling.
Garnett C, Bonate PL, Dang Q, Ferber G, Huang D, Liu J, Mehrotra D, Riley S, Sager P, Tornoe C, Wang Y. Garnett C, et al. J Pharmacokinet Pharmacodyn. 2018 Jun;45(3):383-397. doi: 10.1007/s10928-017-9558-5. Epub 2017 Dec 5. J Pharmacokinet Pharmacodyn. 2018. PMID: 29209907 Review.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: Scientific white paper on concentration-QTc modeling

Affiliations

Correction to: Scientific white paper on concentration-QTc modeling

Authors

Affiliations

Abstract

Erratum for

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources